Summit Therapeutics (SMMT) Asset Utilization Ratio (2020 - 2023)

Summit Therapeutics has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.0 in Q2 2023.

• For the quarter ending Q2 2023, Asset Utilization Ratio fell 95.36% year-over-year to 0.0; the trailing twelve-month figure through Jun 2023 stood at 0.0 (down 95.36% YoY), and the FY2022 full-year result was 0.0, down 89.18% from the prior year.
• Asset Utilization Ratio for Q2 2023 stood at 0.0, down from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.02 in Q2 2022, with the low at 0.0 in Q2 2023.
• Historically, Asset Utilization Ratio has averaged 0.01 across 4 years, with a median of 0.01 in 2022.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 348.67% — and 2023, when it plunged 95.36%.
• Summit Therapeutics' Asset Utilization Ratio stood at 0.01 in 2020, then soared by 38.49% to 0.01 in 2021, then tumbled by 88.49% to 0.0 in 2022, then tumbled by 48.05% to 0.0 in 2023.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.0 (Q4 2022), per Business Quant data.